MCID: LYM006
MIFTS: 46

Lymphoepithelioma-Like Carcinoma

Categories: Cancer diseases, Immune diseases

Aliases & Classifications for Lymphoepithelioma-Like Carcinoma

MalaCards integrated aliases for Lymphoepithelioma-Like Carcinoma:

Name: Lymphoepithelioma-Like Carcinoma 12 14
Lymphoepithelial Carcinoma 12 69
Nasopharyngeal Type Undifferentiated Carcinoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:5660
NCIt 46 C4107
SNOMED-CT 64 7300000
UMLS 69 C0334254

Summaries for Lymphoepithelioma-Like Carcinoma

Disease Ontology : 12 A carcinoma that is a malignant epithelial neoplasm densely infiltrated by lymphoid cells.

MalaCards based summary : Lymphoepithelioma-Like Carcinoma, also known as lymphoepithelial carcinoma, is related to papilloma and basal cell carcinoma. An important gene associated with Lymphoepithelioma-Like Carcinoma is KRT7 (Keratin 7), and among its related pathways/superpathways are Keratinization and Cytoskeletal Signaling. The drugs Cisplatin and Fluorouracil have been mentioned in the context of this disorder. Affiliated tissues include lung, skin and cervix, and related phenotypes are Decreased shRNA abundance (Z-score < -2) and Decreased shRNA abundance (Z-score < -2)

Wikipedia : 72 Lymphoepithelioma-like carcinoma (LELC) is a medical term referring to a histological variant of... more...

Related Diseases for Lymphoepithelioma-Like Carcinoma

Diseases related to Lymphoepithelioma-Like Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 282)
# Related Disease Score Top Affiliating Genes
1 papilloma 30.0 KRT20 KRT5 KRT7 KRT8
2 basal cell carcinoma 29.6 KRT20 KRT5 KRT7 KRT8
3 intrahepatic cholangiocarcinoma 29.6 CDH1 KRT20 KRT7 MUC1
4 papillary carcinoma 29.4 CDH1 KRT20 KRT7 MUC1
5 adenosquamous carcinoma 29.0 KRT18 KRT5 KRT7 KRT8 MUC1
6 cholangiocarcinoma 28.7 CDH1 KRT18 KRT20 KRT7 KRT8 MUC1
7 lung cancer 27.6 CD274 CDH1 ENO2 KRT18 KRT20 KRT7
8 cervical lymphoepithelioma-like carcinoma 12.3
9 infiltrating bladder lymphoepithelioma-like carcinoma 12.3
10 lymphoepithelioma-like thymic carcinoma 11.4
11 endosalpingiosis 10.5 KRT7 MUC1
12 parachordoma 10.5 KRT7 MUC1
13 malignant mixed mullerian tumor 10.5 KRT7 MUC1
14 nodular hidradenoma 10.5 KRT7 MUC1
15 eccrine porocarcinoma 10.5 KRT7 MUC1
16 cystic basal cell carcinoma 10.5 KRT20 KRT7
17 monophasic synovial sarcoma 10.5 KRT7 MUC1
18 lung acinar adenocarcinoma 10.5 KRT20 KRT7
19 nephrogenic adenoma 10.5 KRT7 MUC1
20 vaginal benign neoplasm 10.5 KRT20 KRT7
21 pilomatrix carcinoma 10.5 ENO2 MUC1
22 seminal vesicle adenocarcinoma 10.5 KRT20 KRT7
23 transverse colon cancer 10.5 KRT20 KRT7
24 intracranial cysts 10.5 ENO2 MUC1
25 ovarian large-cell neuroendocrine carcinoma 10.5 KRT20 KRT7
26 vaginal adenoma 10.5 KRT20 KRT7
27 adenomyoma 10.5 KRT7 MUC1
28 vaginal tubulovillous adenoma 10.5 KRT20 KRT7
29 sinonasal undifferentiated carcinoma 10.5 ENO2 MUC1
30 eyelid neoplasm 10.5 KRT20 KRT7
31 malignant syringoma 10.5 KRT20 KRT7
32 krukenberg carcinoma 10.5 KRT20 KRT7
33 eccrine sweat gland neoplasm 10.5 KRT20 KRT7
34 papillary tumor of the pineal region 10.5 ENO2 MUC1
35 epithelioid malignant peripheral nerve sheath tumor 10.5 ENO2 MUC1
36 microcystic adenoma 10.5 ENO2 MUC1
37 vulval paget's disease 10.5 KRT20 KRT7
38 ossifying fibromyxoid tumor 10.5 ENO2 MUC1
39 hidradenoma 10.5 KRT7 MUC1
40 bladder adenocarcinoma 10.5 KRT20 KRT7
41 intratubular embryonal carcinoma 10.5 KRT20 KRT7
42 ovarian mucinous adenocarcinoma 10.5 KRT20 KRT7
43 thymus adenocarcinoma 10.5 KRT20 KRT7
44 well-differentiated liposarcoma 10.5 KRT7 MUC1
45 meibomian cyst 10.5 KRT20 KRT7
46 bladder lymphoma 10.5 KRT20 KRT7
47 vulva adenocarcinoma 10.5 KRT20 KRT7
48 sertoli-leydig cell tumor 10.5 KRT7 MUC1
49 papillary serous adenocarcinoma 10.5 KRT20 KRT7
50 jejunal adenocarcinoma 10.4 KRT20 KRT7

Graphical network of the top 20 diseases related to Lymphoepithelioma-Like Carcinoma:



Diseases related to Lymphoepithelioma-Like Carcinoma

Symptoms & Phenotypes for Lymphoepithelioma-Like Carcinoma

GenomeRNAi Phenotypes related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

25 (show all 12)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance (Z-score < -2) GR00366-A-153 9.58 KRT5
2 Decreased shRNA abundance (Z-score < -2) GR00366-A-154 9.58 KRT18
3 Decreased shRNA abundance (Z-score < -2) GR00366-A-17 9.58 KRT18 KRT5
4 Decreased shRNA abundance (Z-score < -2) GR00366-A-180 9.58 KRT5 KRT8
5 Decreased shRNA abundance (Z-score < -2) GR00366-A-200 9.58 KRT5
6 Decreased shRNA abundance (Z-score < -2) GR00366-A-33 9.58 KRT18
7 Decreased shRNA abundance (Z-score < -2) GR00366-A-40 9.58 KRT8
8 Decreased shRNA abundance (Z-score < -2) GR00366-A-68 9.58 KRT7
9 Decreased shRNA abundance (Z-score < -2) GR00366-A-71 9.58 KRT18 KRT5 KRT7 KRT8
10 Decreased shRNA abundance (Z-score < -2) GR00366-A-72 9.58 KRT7
11 Decreased shRNA abundance (Z-score < -2) GR00366-A-84 9.58 KRT18
12 Decreased shRNA abundance (Z-score < -2) GR00366-A-91 9.58 KRT5 KRT7

Drugs & Therapeutics for Lymphoepithelioma-Like Carcinoma

Drugs for Lymphoepithelioma-Like Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 173)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
2
Fluorouracil Approved Phase 3,Phase 2,Phase 1 51-21-8 3385
3
Carboplatin Approved Phase 2, Phase 3,Phase 1 41575-94-4 10339178 38904 498142
4
Gemcitabine Approved Phase 2, Phase 3,Phase 1 95058-81-4 60750
5
Paclitaxel Approved, Vet_approved Phase 2, Phase 3, Phase 1 33069-62-4 36314
6
Amifostine Approved, Investigational Phase 3,Phase 2 20537-88-6 2141
7
Doxepin Approved, Investigational Phase 3 1668-19-5 667468 667477
8
Histamine Approved, Investigational Phase 3 51-45-6, 75614-87-8 774
9
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
10
Fluconazole Approved, Investigational Phase 2, Phase 3 86386-73-4 3365
11
Miconazole Approved, Investigational, Vet_approved Phase 2, Phase 3,Phase 1 22916-47-8 4189
12
Cevimeline Approved Phase 3 107233-08-9 25137844 83898
13
Megestrol acetate Approved, Investigational, Vet_approved Phase 3 595-33-5 11683
14
Lenograstim Approved, Investigational Phase 3,Phase 2,Phase 1 135968-09-1
15
Docetaxel Approved May 1996, Investigational Phase 3,Phase 2,Phase 1 114977-28-5 148124 9877265
16 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
17 Antimetabolites Phase 3,Phase 2,Phase 1
18 Antimetabolites, Antineoplastic Phase 3,Phase 2,Phase 1
19 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
20 Neurotransmitter Agents Phase 3,Phase 2
21 Analgesics Phase 3,Phase 2
22 Liver Extracts Phase 3,Phase 2,Phase 1
23 Peripheral Nervous System Agents Phase 3,Phase 2
24 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
25 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
26 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2,Phase 1
27 Anti-Infective Agents Phase 2, Phase 3, Phase 1
28 Cytochrome P-450 Enzyme Inhibitors Phase 2, Phase 3
29 Autonomic Agents Phase 3,Phase 2
30 Albumin-Bound Paclitaxel Phase 2, Phase 3, Phase 1
31 Antimitotic Agents Phase 2, Phase 3, Phase 1
32 Antineoplastic Agents, Phytogenic Phase 2, Phase 3, Phase 1
33 Antiviral Agents Phase 2, Phase 3,Phase 1
34 Protective Agents Phase 3,Phase 2
35 Radiation-Protective Agents Phase 3,Phase 2
36 Antidepressive Agents Phase 3
37 Antidepressive Agents, Tricyclic Phase 3
38 Histamine Antagonists Phase 3
39
Histamine Phosphate Phase 3 51-74-1 65513
40 Psychotropic Drugs Phase 3
41 Adjuvants, Anesthesia Phase 3
42 Analgesics, Opioid Phase 3
43 Anesthetics Phase 3
44 Anesthetics, General Phase 3
45 Anesthetics, Intravenous Phase 3
46 Central Nervous System Depressants Phase 3
47 Narcotics Phase 3
48 Alkylating Agents Phase 3,Phase 2
49 Mitomycins Phase 3
50 Porfiromycin Phase 3

Interventional clinical trials:

(show top 50) (show all 93)

# Name Status NCT ID Phase Drugs
1 Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx Unknown status NCT00003637 Phase 3 cisplatin;fluorouracil
2 Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer Completed NCT00274937 Phase 3 amifostine trihydrate;fluorouracil;cisplatin
3 Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy Completed NCT01156142 Phase 3 doxepin hydrochloride
4 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
5 Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer Completed NCT00090337 Phase 3
6 Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer Completed NCT00002507 Phase 3 mitomycin C;porfiromycin
7 Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer Completed NCT00002533 Phase 2, Phase 3 fluconazole
8 Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer Completed NCT00017511 Phase 3 cevimeline hydrochloride
9 Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer Completed NCT00006799 Phase 3 megestrol acetate
10 Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract Completed NCT00765440 Phase 3
11 Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck Completed NCT00771641 Phase 3
12 Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC Active, not recruiting NCT00997906 Phase 2, Phase 3 carboplatin,;cisplatin;gemcitabine hydrochloride;paclitaxel
13 Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Terminated NCT00113399 Phase 3 cisplatin;docetaxel;fluorouracil;paclitaxel
14 Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Withdrawn NCT00041171 Phase 3 Hypericum perforatum;docetaxel
15 Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer Unknown status NCT00690872 Phase 2 carboplatin;gemcitabine hydrochloride
16 Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer Unknown status NCT00589186 Phase 2 celecoxib
17 Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer Unknown status NCT00093665 Phase 2 cisplatin;fluorouracil
18 Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer Unknown status NCT00625937 Phase 2 cisplatin;docetaxel;tegafur-gimeracil-oteracil potassium
19 Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer Unknown status NCT00022217 Phase 2 carboplatin;cisplatin-e therapeutic implant;paclitaxel
20 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
21 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx Unknown status NCT00004094 Phase 2 carboplatin;fluorouracil;hydroxyurea;paclitaxel
22 Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer Unknown status NCT00468169 Phase 2 Cetuximab
23 Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer Unknown status NCT00387530 Phase 2 oral sodium phenylbutyrate;valganciclovir
24 Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck Completed NCT00084318 Phase 2 cisplatin;docetaxel
25 Imatinib Mesylate in Treating Patients With Salivary Gland Cancer Completed NCT00045669 Phase 2 imatinib mesylate
26 Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer Completed NCT00454142 Phase 2 pazopanib hydrochloride
27 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2 bevacizumab;placebo
28 Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer Completed NCT00101348 Phase 1, Phase 2 erlotinib hydrochloride
29 High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer Completed NCT00052429 Phase 1, Phase 2 cisplatin;fluorouracil
30 Chemotherapy in Treating Patients With Solid Tumors Completed NCT00003103 Phase 1, Phase 2 docetaxel
31 High-dose ICE With Amifostine Completed NCT00003657 Phase 2 Amifostine;Carboplatin;Etoposide;Ifosfamide
32 Docetaxel in Treating Patients With Solid Tumors Completed NCT00003565 Phase 2 docetaxel
33 Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer Completed NCT00448552 Phase 2 capecitabine;oxaliplatin
34 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer Completed NCT00004901 Phase 1, Phase 2 ethynyluracil;fluorouracil;hydroxyurea
35 Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor Completed NCT00021047 Phase 1, Phase 2 capecitabine;carboplatin;epirubicin hydrochloride
36 Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors Completed NCT00019331 Phase 2 DetoxPC
37 Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer Completed NCT00509665 Phase 2 doxorubicin hydrochloride;gemcitabine hydrochloride
38 Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer Completed NCT00021333 Phase 2 cisplatin;paclitaxel
39 Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer Completed NCT00002515 Phase 2 carboplatin;thiotepa;topotecan hydrochloride
40 Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC) Recruiting NCT00896181 Phase 2 docetaxel;cisplatin;carboplatin;fluorouracil
41 18F FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy Recruiting NCT01806675 Phase 1, Phase 2 fludeoxyglucose F 18;2-fluoropropionyl-labeled pegylated dimeric RGD peptide
42 MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer Unknown status NCT00984074 Phase 1
43 Functional MRI in Finding Hypoxia in Patients Undergoing Chemotherapy and Radiation Therapy for Stage III or Stage IV Head and Neck Cancer Unknown status NCT00896350 Phase 1 chemotherapy
44 Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer Completed NCT01637194 Phase 1 everolimus
45 Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors Completed NCT00089362 Phase 1 alvespimycin hydrochloride
46 Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer Completed NCT00023959 Phase 1 hydroxyurea;fluorouracil
47 Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer Completed NCT00397384 Phase 1 cetuximab;erlotinib hydrochloride
48 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) Completed NCT00031681 Phase 1 7-hydroxystaurosporine;irinotecan hydrochloride
49 Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction Completed NCT00030498 Phase 1 erlotinib hydrochloride
50 Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors Completed NCT01172028 Phase 1 Taxotere (Docetaxel);Alimta (Pemetrexed)

Search NIH Clinical Center for Lymphoepithelioma-Like Carcinoma

Genetic Tests for Lymphoepithelioma-Like Carcinoma

Anatomical Context for Lymphoepithelioma-Like Carcinoma

MalaCards organs/tissues related to Lymphoepithelioma-Like Carcinoma:

38
Lung, Skin, Cervix, Brain, Liver, Salivary Gland, Breast

Publications for Lymphoepithelioma-Like Carcinoma

Articles related to Lymphoepithelioma-Like Carcinoma:

(show top 50) (show all 321)
# Title Authors Year
1
Primary pulmonary lymphoepithelioma-like carcinoma in Singapore. ( 29387253 )
2018
2
Lymphoepithelioma-like carcinoma of the large intestine: A case report and literature review. ( 29290316 )
2018
3
Prognosis and distribution of lymph nodes metastases in resectable primary pulmonary lymphoepithelioma-like carcinoma: A large cohort from a single center. ( 29327422 )
2018
4
Clinical Significance of Plasma Epstein-Barr Virus DNA in Pulmonary Lymphoepithelioma-like Carcinoma (LELC) Patients. ( 29191777 )
2018
5
Lymphoepithelioma-Like Carcinoma of the Breast Mimicking Granulomatous Mastitis- Case Report and Review of the Literature ( 28749097 )
2017
6
Lymphoepithelioma-Like Carcinoma of the Esophagus: A Rare Tumor. ( 28969745 )
2017
7
Inflammatory Stroma of Lymphoepithelioma-like Carcinoma of the Cervix: Immunohistochemical Study of 3 Cases and Review of the Literature. ( 28985196 )
2017
8
Lymphoepithelioma-Like Carcinoma in Liver. ( 28500863 )
2017
9
Lymphoepithelioma-like carcinoma of the upper urinary tract. ( 28455741 )
2017
10
Primary lymphoepithelioma-like carcinoma of the urinary bladder. ( 28757780 )
2017
11
Lymphoepithelioma-like carcinoma of the uterine cervix. ( 28217683 )
2017
12
(18)F-FDG PET/CT of common hepatic duct lymphoepithelioma-like carcinoma. ( 27836588 )
2017
13
Lymphoepithelioma-like carcinoma of the ureter: a rare presentation, synchronous with conventional urothelial carcinoma. ( 28263136 )
2017
14
Response of advanced stage recurrent lymphoepithelioma-like carcinoma to nivolumab. ( 28971752 )
2017
15
Primary pure lymphoepithelioma-like carcinoma of the ureter. ( 28699107 )
2017
16
Advanced primary pulmonary lymphoepithelioma-like carcinoma: clinical manifestations, treatment, and outcome. ( 28203414 )
2017
17
Lymphoepithelioma-like Carcinoma of the Uterine Cervix: Cytomorphologic Features and Diagnostic Pitfalls by Liquid-Based Cytology. ( 29218797 )
2017
18
In reply to: letter to the editor entitled: primary pure lymphoepithelioma-like carcinoma of the ureter. ( 28844115 )
2017
19
Primary Pulmonary Lymphoepithelioma-like Carcinoma on FDG PET/CT. ( 28250863 )
2017
20
Lymphoepithelioma-like carcinoma of the urinary bladder: A case report. ( 29179966 )
2017
21
Lymphoepithelioma-like carcinoma of cervix: Cytological Features on Conventional Cervical Smear. ( 28211234 )
2017
22
Primary lymphoepithelioma-like carcinoma of the lung: An unusual cancer and clinical outcomes of 14 patients. ( 28928848 )
2017
23
Human Papillomavirus (HPV)-associated Lymphoepithelioma-like Carcinoma of the Vagina and Anal Canal: A Rare Variant of Squamous Cell Carcinoma. ( 29257037 )
2017
24
Collision of Lymphoepithelioma-like Carcinoma with Diffuse Large B-cell Lymphoma of the Stomach: A Case Report. ( 28739754 )
2017
25
Lymphoepithelioma-Like Carcinoma of the Skin-A Rare Tumor Treated by Slow Mohs Micrographic Surgery. ( 27846013 )
2016
26
Unusual presentation of pulmonary lymphoepithelioma-like carcinoma. ( 27516893 )
2016
27
Pulmonary lymphoepithelioma-like carcinoma with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK) fusion gene. ( 28031835 )
2016
28
Pure Lymphoepithelioma-Like Carcinoma Originating from the Urinary Bladder. ( 27099604 )
2016
29
Mixed lymphoepithelioma-like carcinoma and adenocarcinoma of the gallbladder. ( 27621754 )
2016
30
(18)F-FDG PET/CT in gastric lymphoepithelioma-like carcinoma. ( 26746813 )
2016
31
An Unusual Case of Lymphoepithelioma-Like Carcinoma of the External Auditory Canal. ( 27755455 )
2016
32
Cytological features of lymphoepithelioma-like carcinoma of the breast. ( 27478161 )
2016
33
Metastatic lymphoepithelioma-like carcinoma of the lung treated with nivolumab: a case report and focused review of literature. ( 28149767 )
2016
34
Dermoscopic Features of Cutaneous Lymphoepithelioma-like Carcinoma. ( 27930377 )
2016
35
Extensive Metastases on 18F-FDG PET/CT in Primary Lymphoepithelioma-Like Carcinoma of the Ovary. ( 27607167 )
2016
36
A case of lymphoepithelioma-like carcinoma of the uterine cervix in a patient with a history of high-grade squamous intraepithelial lesion. ( 27343338 )
2016
37
Lymphoepithelioma-like carcinoma of breast-evaluation for Epstein-Barr virus-encoded RNA, human papillomavirus, and markers of basal cell differentiation. ( 27806845 )
2016
38
Lymphoepithelioma-like carcinoma of the breast - A case report and brief review of the literature. ( 27773103 )
2016
39
Lymphoepithelioma-like Carcinoma (LELC) of the Prostate. ( 26977409 )
2016
40
Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma. ( 27747015 )
2016
41
Lymphoepithelioma-like carcinoma of the bladder: A case report. ( 27377093 )
2016
42
Primary Lymphoepithelioma-Like Carcinoma of the Prostate Gland: A Review of the Literature. ( 26881187 )
2016
43
Surgical treatment for primary pulmonary lymphoepithelioma-like carcinoma. ( 26993476 )
2016
44
Utility of 18F-FDG PET/CT in the assessment of lymphoepithelioma-like carcinoma. ( 26741291 )
2016
45
A rare case of non-Epstein-Barr virus-associated lymphoepithelioma-like carcinoma of the esophagus treatedA withA endoscopic submucosal dissection. ( 26297869 )
2015
46
Detection of rearrangement of anaplastic lymphoma kinase (ALK) and mutation of epidermal growth factor receptor (EGFR) in primary pulmonary lymphoepithelioma-like carcinoma. ( 26543602 )
2015
47
External beam radiotherapy for focal lymphoepithelioma-like carcinoma in the urinary bladder: a case report and literature review. ( 25759655 )
2015
48
Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinoma. ( 26109869 )
2015
49
Lymphoepithelioma-like carcinoma of the skin in a Polish patient. ( 25821429 )
2015
50
Intrahepatic Cholangiocarcinoma With Lymphoepithelioma-like Carcinoma Components Not Associated With Epstein-Barr Virus: Report of a Case. ( 25875552 )
2015

Variations for Lymphoepithelioma-Like Carcinoma

Expression for Lymphoepithelioma-Like Carcinoma

Search GEO for disease gene expression data for Lymphoepithelioma-Like Carcinoma.

Pathways for Lymphoepithelioma-Like Carcinoma

Pathways related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.81 KRT18 KRT20 KRT5 KRT7 KRT8
2 11.66 CDH1 KRT18 KRT20 KRT5 KRT7 KRT8
3 11.59 CD274 CDH1 PDCD1
4
Show member pathways
11.49 KRT18 KRT5 KRT7 KRT8

GO Terms for Lymphoepithelioma-Like Carcinoma

Cellular components related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.76 CD274 CDH1 ENO2 KRT18 KRT5 KRT7
2 keratin filament GO:0045095 9.26 KRT18 KRT5 KRT7 KRT8
3 intermediate filament GO:0005882 9.02 KRT18 KRT20 KRT5 KRT7 KRT8

Biological processes related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 keratinization GO:0031424 9.35 KRT18 KRT20 KRT5 KRT7 KRT8
2 hepatocyte apoptotic process GO:0097284 9.16 KRT18 KRT8
3 cornification GO:0070268 9.02 KRT18 KRT20 KRT5 KRT7 KRT8

Molecular functions related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 9.65 CD274 CDH1 ENO2 KRT18 KRT20 KRT5
2 structural molecule activity GO:0005198 9.33 KRT18 KRT7 KRT8
3 scaffold protein binding GO:0097110 8.8 KRT18 KRT5 KRT8

Sources for Lymphoepithelioma-Like Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....